What Is The Current and Historic Market Size Analysis Of The Human Chorionic Gonadotropin Market?
The human chorionic gonadotropin market has seen considerable growth due to a variety of factors.
• The human chorionic gonadotropin (HCG) market has experienced strong growth in recent years. It will rise from $0.95 billion in 2024 to $1.03 billion in 2025, at a compound annual growth rate (CAGR) of 8.7%.
The growth is attributed to the increasing prevalence of hypogonadism in the elderly, growing awareness of HCG among healthcare professionals and patients, the popularity of fertility tourism, the aging population, and improvements in healthcare accessibility and affordability.
What Are The Predictions for The Human Chorionic Gonadotropin Market in the Coming Years?
The human chorionic gonadotropin market is expected to maintain its strong growth trajectory in upcoming years.
• The human chorionic gonadotropin market is expected to grow to $1.42 billion by 2029, with a CAGR of 8.4%.
The market growth is attributed to the rise in infertility cases, the prevalence of polycystic ovary syndrome, female infertility, and the use of HCG in veterinary medicine. Trends include advancements in pregnancy detection, innovative drug formulations, technological integration, and increased R&D.
Which Drivers Are Accelerating Growth In The Human Chorionic Gonadotropin Market?
The rising infertility rates are expected to drive the growth of the human chorionic gonadotropin (hCG) market. Factors like delayed childbearing, lifestyle changes, and medical conditions contribute to the increasing infertility rates. hCG is widely used in infertility treatments, supporting ovulation in women and testosterone production in men. The World Health Organization reported that 17.5% of adults globally experience infertility, underscoring the need for effective fertility treatments.
What Are The Core Segments Of The Global Human Chorionic Gonadotropin Market?
The human chorionic gonadotropin market covered in this report is segmented –
1) By Technology: Natural Source Extraction, Recombinant Technology
2) By Therapeutic Area: Female Infertility Treatment, Oligospermic Treatment, Male Hypogonadism, Other Therapeutic Areas
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
4) By End User: Fertility Clinics, Research Institutions, Other End Users
Subsegments:
1) By Natural Source Extraction: Extraction From Pregnant Women's Urine, Extraction From Animal Sources
2) By Recombinant Technology: Recombinant Hcg, Recombinant Hcg For Therapeutic Use, Recombinant Hcg For Diagnostic Applications
Pre-Book The Human Chorionic Gonadotropin Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What New Trends Are Influencing The Human Chorionic Gonadotropin Market?
Leading businesses in the market for human chorionic gonadotropin are concentrating on the creation of novel products including pregnancy detection kits, with the aim of boosting diagnostic precision, enhancing patient results, and broadening their market presence. Pregnancy detection kits serve as devices that confirm pregnancy by identifying human chorionic gonadotropin (hCG) in the body. For example, in June 2022, Proov, a medical equipment manufacturer based in the US, introduced new hCG tests designed specifically for the early detection of pregnancy, which allows women to confirm their pregnancy up to six days prior to their estimated period. These tests work by detecting the existence of human chorionic gonadotropin (hCG) in the urine and provide high precision, with a trustworthiness rate of over 99. This development aims to offer women a reliable and accessible way to check their pregnancy status sooner than conventional tests, enabling them to make educated decisions about their reproductive wellbeing.
Who Are the Key Players In The Human Chorionic Gonadotropin Market?
Major companies operating in the human chorionic gonadotropin market are:
• Pfizer Inc.
• Merck & Co Inc.
• Novartis AG
• Bristol-Myers Squibb Company
• Fresenius Kabi AG
• Janssen Pharmaceuticals Inc.
• Teva Pharmaceutical Industries Ltd.
• Sandoz International GmbH
• Sun Pharmaceutical Industries Limited
• Menarini Group
• Cipla Limited
• Hikma Pharmaceuticals plc
• Ferring Pharmaceuticals Inc.
• Intas Pharmaceuticals Ltd.
• Zydus Lifesciences Limited
• Lupin Limited
• Shenzhen Hepalink Pharmaceutical Group Co. Ltd.
• Scripps Laboratories Inc.
• Aspen Pharmacare Holdings Limited
• Corona Remedies Pvt Ltd.
• Sanzyme Private Limited
• Biocare Medical LLC
• Lee BioSolutions Inc.
• MyBioSource Inc.
What Are The Regional Insights Into The Human Chorionic Gonadotropin Market?
North America was the largest region in the human chorionic gonadotropin market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the human chorionic gonadotropin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
